Form 4: Pharvaris Director Adjusts Holdings

Pharvaris N.V. director Viviane Monges has corrected previously reported beneficial ownership and disposed of shares.

Summary

• Viviane Monges, a Director at Pharvaris N.V., has filed a Form 4 to amend previous filings and report a transaction.
• The filing corrects an understatement of 513 shares in beneficial ownership, attributed to administrative errors regarding shares withheld for tax obligations from RSU releases on April 11, 2025, and March 12, 2026.
• Monges sold 9,667 shares of common stock on May 21, 2026, at a weighted average price of $30.2941 per share.
• The sale involved multiple transactions with prices ranging from $30.08 to $30.49 per share.
• These shares were acquired upon the vesting of restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves a director selling shares and correcting a reporting error, the context suggests it's related to standard equity compensation practices rather than a negative outlook on the company's future.

Positives

• Correction of previously understated beneficial ownership demonstrates a commitment to accurate reporting.
• The sale was executed at a weighted average price reflecting market conditions at the time.

Negatives

• An administrative error led to an understatement of beneficial ownership by 513 shares.
• A significant number of shares (9,667) were disposed of by a director.

Risks

• Potential for further administrative errors in reporting beneficial ownership.
• Director stock sales can sometimes be interpreted negatively by the market, suggesting a lack of confidence, although this is a Form 4 filing which often relates to routine vesting and tax withholding.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports past transactions and ownership adjustments.

Management Comments

• The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. While director sales can sometimes signal sentiment, this filing appears to be primarily an administrative correction and a sale related to RSU vesting and tax obligations, which is common in the biotechnology and pharmaceutical sectors where equity-based compensation is prevalent.

Stakeholder Impact

• Shareholders may note the director's sale of shares, though the context of RSU vesting and tax withholding mitigates potential negative interpretation.
• The correction of beneficial ownership errors enhances transparency for all stakeholders.

Next Steps

• The reporting person has undertaken to provide further details on share sales at specific prices upon request.

Key Dates

Keywords

Pharvaris N.V., PHVS, Form 4, Beneficial Ownership, Stock Sale, Director Transaction, Restricted Stock Units, Vesting, SEC Filing